Schweiz durchsuchen · Zurich · Assistenzdirektor
Turner & Townsend Pty Ltd
Develop and manage a suite of governance, communication and management control systems for the proper conduct and assured delivery of the client’s essential services and works
Turner & Townsend Pty Ltd
Develop and manage a suite of governance, communication and management control systems for the proper conduct and assured delivery of the client’s essential services and works
Laboratory Animal Management Association
This role will be responsible for designing and implementing a patient financing navigator for prioritized assets in prioritized markets
Takeda
The Associate Director, Site Start-Up and Maintenance plays a pivotal leadership role within the global clinical operations team, overseeing strategic planning and execution of global site regulatory, budgeting, and contracting maintenance activities
Takeda
Define, develop, and lead the regional regulatory strategy within the EUCAN region for a key late-phase oncology asset with multiple indications
Takeda
Lead regional regulatory strategy for assigned assets, driving submission excellence across development, registration, and life-cycle management to enable timely patient access
Takeda
Contributes to the development of regulatory strategy for assigned clinical trials in Europe & Canada (EUCAN) and Growth & Emerging Markets (GEM) regions
Biogen
The Associate Director, Global Program Management will lead complex, cross-functional programs spanning Medical, Regulatory, Clinical Development, Quality, Supply Chain, and Commercial interfaces
Bilbr
The Associate Director, Global Program Management will lead complex, cross-functional programs spanning Medical, Regulatory, Clinical Development, Quality, Supply Chain, and Commercial interfaces
Biogen
The Associate Director, Global Program Management will lead complex, cross-functional programs spanning Medical, Regulatory, Clinical Development, Quality, Supply Chain, and Commercial interfaces
MSD (Merck)
This role will be responsible for designing and implementing a patient financing navigator for prioritized assets in prioritized markets
Takeda UK
At Takeda, we are a forward-looking, world-class R&D organization that unlocks innovation and delivers transformative therapies to patients
Takeda UK
The role involves contributing to the regulatory strategy for clinical trials across various therapeutic areas
Takeda UK
The Associate Director plays a pivotal leadership role within the global clinical operations team
Takeda UK
At Takeda, we are committed to unlocking innovation and delivering transformative therapies to patients
Biogen
The Associate Director, Global Regulatory Strategy will be responsible for developing and delivering innovative, breakthrough global and EU regulatory strategies for product development and approval, in alignment with the global business strategy
Biogen
You will play a pivotal role in shaping and executing the global Regulatory Chemistry, Manufacturing and Controls (RegCMC) strategy for Biogen’s small molecule portfolio
Biogen
The Associate Director, Global Regulatory Strategy will be responsible for developing and delivering innovative, breakthrough global and EU regulatory strategies for product development and approval, in alignment with the global business strategy
Biogen
You will be responsible for leading cross-functional regulatory CMC activities to ensure timely preparation and delivery of high-quality regulatory submissions that support product development, registration, and lifecycle management
Takeda
The Associate Director plays a pivotal leadership role within the global clinical operations team
Takeda
This role is crucial for Takeda's growing oncology portfolio, focusing on regulatory strategy within the EUCAN region
Takeda
At Takeda, we are a forward-looking, world-class R&D organization that unlocks innovation and delivers transformative therapies to patients
Takeda
The role involves contributing to regulatory strategy for clinical trials in Europe and Canada
Takeda
Define, develop, and lead the regional regulatory strategy within the EUCAN region for a key late-phase oncology asset with multiple indications
